12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
- Outset Medical (NASDAQ:OM) stock increased by 27.2% to $16.5 during Wednesday's after-market session. The company's market cap stands at $249.8 million. The company's, Q2 earnings came out today.
- Niagen Bioscience (NASDAQ:NAGE) stock rose 26.44% to $11.9. The market value of their outstanding shares is at $721.5 million. As per the news, the Q2 earnings report came out today.
- Guardant Health (NASDAQ:GH) shares moved upwards by 21.2% to $54.04. The company's market cap stands at $5.7 billion.
- Mirum Pharmaceuticals (NASDAQ:MIRM) stock moved upwards by 8.63% to $58.0. The company's market cap stands at $2.5 billion. As per the news, the Q2 earnings report came out today.
- Emergent BioSolutions (NYSE:EBS) shares moved upwards by 8.45% to $6.54. The company's market cap stands at $331.0 million. The company's, Q2 earnings came out today.
- TAO Synergies (NASDAQ:TAOX) shares increased by 8.4% to $6.77. The market value of their outstanding shares is at $13.7 million.
Losers
- Tandem Diabetes Care (NASDAQ:TNDM) stock decreased by 17.7% to $11.85 during Wednesday's after-market session. The market value of their outstanding shares is at $1.0 billion. The company's, Q2 earnings came out today.
- Sana Biotechnology (NASDAQ:SANA) shares declined by 16.95% to $3.53. The market value of their outstanding shares is at $960.8 million.
- Exact Sciences (NASDAQ:EXAS) stock decreased by 16.01% to $39.4. The company's market cap stands at $8.9 billion. The company's, Q2 earnings came out today.
- Eledon Pharmaceuticals (NASDAQ:ELDN) shares declined by 14.25% to $2.95. The company's market cap stands at $187.4 million.
- electroCore (NASDAQ:ECOR) stock fell 14.15% to $5.95. The market value of their outstanding shares is at $51.2 million. As per the news, the Q2 earnings report came out today.
- BiomX (AMEX:PHGE) stock decreased by 14.0% to $0.56. The market value of their outstanding shares is at $11.3 million.
See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
